Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precedex(Registered) Intravenous Solution Special Investigation (in Pediatric Patients)

NCT04040439 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04040439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04040439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precedex(Registered) Intravenous Solution Special Investigation (in Pediatric Patients)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 30, 2019
Completion date
August 8, 2022
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sedation